Weiss Asset Management LP Raises Position in Humana Inc. $HUM

Weiss Asset Management LP boosted its holdings in shares of Humana Inc. (NYSE:HUM) by 45.0% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm owned 40,891 shares of the insurance provider’s stock after buying an additional 12,685 shares during the period. Weiss Asset Management LP’s holdings in Humana were worth $7,090,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also added to or reduced their stakes in HUM. Delta Global Management LP bought a new stake in shares of Humana during the 1st quarter valued at about $957,000. OMERS ADMINISTRATION Corp increased its position in shares of Humana by 31.2% in the first quarter. OMERS ADMINISTRATION Corp now owns 5,738 shares of the insurance provider’s stock worth $995,000 after purchasing an additional 1,364 shares during the last quarter. Lombard Odier Asset Management Switzerland SA bought a new position in shares of Humana in the first quarter worth approximately $535,000. Sustainable Insight Capital Management LLC raised its stake in Humana by 24.4% in the first quarter. Sustainable Insight Capital Management LLC now owns 30,797 shares of the insurance provider’s stock valued at $5,340,000 after purchasing an additional 6,040 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund raised its stake in Humana by 3,350.6% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 336,572 shares of the insurance provider’s stock valued at $58,358,000 after purchasing an additional 326,818 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

HUM has been the subject of a number of research reports. Evercore boosted their price target on shares of Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. Zacks Research raised shares of Humana from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Leerink Partners upped their target price on shares of Humana from $185.00 to $255.00 and gave the stock a “market perform” rating in a research report on Thursday, April 30th. UBS Group reissued a “neutral” rating on shares of Humana in a research note on Monday, June 15th. Finally, Sanford C. Bernstein reaffirmed an “outperform” rating and set a $425.00 price target on shares of Humana in a research note on Wednesday, June 3rd. Two equities research analysts have rated the stock with a Strong Buy rating, nine have assigned a Buy rating, fifteen have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, Humana presently has an average rating of “Hold” and an average target price of $327.17.

Humana Stock Down 1.5%

HUM opened at $388.56 on Friday. The company has a market cap of $46.65 billion, a P/E ratio of 41.56, a P/E/G ratio of 2.12 and a beta of 0.71. The business’s 50-day moving average price is $364.10 and its 200-day moving average price is $265.01. The company has a current ratio of 1.77, a quick ratio of 1.77 and a debt-to-equity ratio of 0.66. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88.

Humana (NYSE:HUM) last released its earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion during the quarter, compared to analyst estimates of $39.37 billion. Humana had a return on equity of 10.45% and a net margin of 0.82%.Humana’s revenue for the quarter was up 23.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $11.58 EPS. Humana has set its FY 2026 guidance at 9.000- EPS. On average, equities analysts expect that Humana Inc. will post 9.46 EPS for the current year.

Humana Profile

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.